Compliance considerations with hormone replacement therapy.
OBJECTIVE
The purpose of this study was to determine women's own reasons for postmenopausal hormone replacement therapy (HRT) utilization and discontinuation in a Turkish population and to investigate the variables that have influenced the compliance to treatment.


METHODS
The study was comprised of 613 postmenopausal women who presented to the Menopause Unit in the Marmara University Hospital.


RESULTS
A total of 437 women (71.2%) reported that they continued using postmenopausal HRT and 176 women (28.7%) discontinued treatment with an average 4.5 months duration of use (range 1-60 months). Hot flashes was the most common reason for initiating therapy (258 women, 42.0%). Prevention of osteoporosis was mentioned by 149 (24.3%) women as a reason to begin HRT. Bleeding episodes (44.8%) was the most common factor in the patient's decision to discontinue HRT. Continuation of HRT was significantly more common among women who started HRT either because of physician recommendation or osteoporosis concern (p < 0.05). Additionally, a greater percentage of surgically menopausal women began and continued HRT (p < 0.0001) than naturally menopausal women. The educational status of the patients was directly related to incidence of beginning HRT but was not related to the discontinuation of HRT.


CONCLUSIONS
Education of menopausal women about the long-term benefits of HRT is critical in improving compliance.
Karakoç
B
B
Department of Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey.
Erenus
M
M
D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D004522:Educational Status; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000523:psychology / Q000706:statistics & numerical data*; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy; D006801:Humans; D007407:Interviews as Topic; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced / Q000523:psychology; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010349:Patient Compliance; D013997:Time Factors; D014421:Turkey; D014592:Uterine Hemorrhage / Q000139:chemically induced